Insider holders · CIK 0001781174
Acrivon Therapeutics, Inc. · ACRV
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Kristina MassonEVP - Business Operations | 2,230,052 | 385,859 | 2,615,911 | Aug 27, 2026 · 4:14 pm EDT | Form 4 |
| Peter Blume-JensenPresident and CEO | 2,230,052 | 385,859 | 2,615,911 | Aug 27, 2026 · 4:14 pm EDT | Form 4 |
| Eric DevroeChief Operating Officer | 146,349 | — | 146,349 | Aug 20, 2026 · 4:07 pm EDT | Form 4 |
| Mary MillerChief Legal Officer | 82,009 | — | 82,009 | Aug 20, 2026 · 4:09 pm EDT | Form 4 |
| Adam D. LevyChief Financial Officer | 66,008 | — | 66,008 | Aug 6, 2026 · 4:34 pm EDT | Form 4 |
| Erick GamelinChief Development Officer | 52,592 | — | 52,592 | Aug 20, 2026 · 4:08 pm EDT | Form 4 |
| Michaela LevinChief Business Officer | 30,000 | — | 30,000 | Sep 2, 2026 · 4:30 pm EDT | Form 4 |
| Katharine PetersonChief Accounting Officer | 18,033 | — | 18,033 | Aug 20, 2026 · 4:10 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.